Tetrahedron
ACCEPTED MANUSCRIPT
5
1H NMR (400 MHz, CDCl3): δ 8.71 (s, 1H), 7.78 (d, J=8.4 Hz,
1H NMR (400 MHz, CDCl3): δ 8.01 (d, J=7.8 Hz, 2H), 7.78 (d,
2H), 7.44 (d, J=8.8 Hz, 2H), 7.36 (d, J=8.0 Hz, 2H), 7.30–7.22
(m, 2H), 4.18 (s, 2H), 2.44 (s, 3H) ppm. 13C NMR (100 MHz,
CDCl3): δ 158.8, 146.0, 135.6, 134.8, 130.2, 129.7, 129.1, 128.1,
121.4, 63.0, 21.7 ppm. HRMS (ESI) m/z: calcd for
C15H14ClNNaO3S [M+Na]+, 346.0275; found 346.0283.
J=7.8 Hz, 2H), 7.62 (d, J=7.4 Hz, 2H), 7.51–7.42 (m, 3H), 4.20–
4.15 (m, 4H), 1.21 (t, J=7.0 Hz, 3H). 13C NMR (100 MHz,
CDCl3): δ 162.4, 147.2, 139.0, 137.2, 129.1, 128.8, 127.8, 127.4,
62.4, 61.1, 13.8.
4.2.20. 2-(Methylsulfonyl)-1-phenylethanone (3ag)
1H NMR (400 MHz, CDCl3): δ 8.00 (d, J=7.2 Hz, 2H), 7.66 (t,
J=7.4 Hz, 1H), 7.53 (t, J=7.8 Hz, 2H), 4.61 (s, 2H), 3.15 (s, 3H)
ppm. 13C NMR (100 MHz, CDCl3): δ 189.2, 135.6, 134.7, 129.2,
129.0, 61.2, 41.8 ppm. HRMS (ESI) m/z: calcd for C9H10NaO3S
[M+Na]+, 221.0243; found 221.0249.
4.2.12. N-(o-Tolyl)-2-tosylacetamide (3la)
1H NMR (400 MHz, CDCl3): δ 8.46 (s, 1H), 7.81 (d, J=8.0 Hz,
2H), 7.72 (t, J=6.8 Hz, 1H), 7.35 (d, J=7.6 Hz, 2H), 7.22–7.15
(m, 2H), 7.09 (t, J=7.2 Hz, 1H), 4.19 (s, 2H), 2.43 (s, 3H), 2.32
(d, J=2.8 Hz, 3H) ppm. 13C NMR (100 MHz, CDCl3): δ 158.8,
145.8, 135.1, 135.0, 130.6, 130.2, 128.0, 126.6, 125.7, 122.8,
122.7, 62.5, 21.6, 17.7 ppm. HRMS (ESI) m/z: calcd for
C16H17NNaO3S [M+Na]+, 326.0821; found 326.0830.
4.2.21. 2-(Ethylsulfonyl)-1-phenylethanone (3ah)
1H NMR (400 MHz, CDCl3): δ 8.00 (d, J=7.6 Hz, 2H), 7.64 (t,
J=7.2 Hz, 1H), 7.51 (t, J=7.6 Hz, 2H), 4.57 (s, 2H), 3.27 (q,
J=7.2 Hz, 2H), 1.44 (t, J=7.2 Hz, 3H) ppm. 13C NMR (100 MHz,
CDCl3): δ 189.2, 135.7, 134.6, 129.2, 128.9, 58.7, 48.2, 6.5 ppm.
HRMS (ESI) m/z: calcd for C10H12NaO3S [M+Na]+, 235.0399;
found 235.0404.
4.2.13. 1-Phenyl-2-tosylethanone (3ma)
1H NMR (400 MHz, CDCl3): δ 7.95 (d, J=7.2 Hz, 2H), 7.76 (d,
J=8.0 Hz, 2H), 7.62 (t, J=7.2 Hz, 1H), 7.48 (t, J=8.0 Hz, 2H),
7.33 (d, J=8.0 Hz, 2H), 4.72 (s, 2H), 2.44 (s, 3H) ppm. 13C NMR
(100 MHz, CDCl3): δ 188.1, 145.3, 135.8, 134.3, 129.8, 129.3,
128.8, 128.6, 127.4, 63.6, 21.7 ppm. HRMS (ESI) m/z: calcd for
C15H14NaO3S [M+Na]+, 297.0556; found 297.0560.
4.2.22. 2-(Cyclopropylsulfonyl)-1-phenylethanone (3ai)
1H NMR (400 MHz, CDCl3): δ 8.05 (dd, J=8.4, 1.2 Hz, 2H), 7.68
(t, J=7.4 Hz, 1H), 7.54 (t, J=7.8 Hz, 2H), 4.67 (s, 2H), 2.81–2.75
(m, 1H), 1.31–1.28 (m, 2H), 1.14–1.09 (m, 2H) ppm. 13C NMR
(100 MHz, CDCl3): δ 188.9, 135.8, 134.5, 129.3, 129.0, 61.0,
30.8, 5.5 ppm. HRMS (ESI) m/z: calcd for C11H12NaO3S
[M+Na]+, 247.0399; found 247.0406.
4.2.14. 1-(Furan-2-yl)-2-tosylethanone (3na)
1H NMR (400 MHz, CDCl3): δ 7.76 (d, J=8.0 Hz, 2H), 7.61 (s,
1H), 7.35–7.31 (m, 3H), 6.58 (s, 1H), 4.57 (s, 2H), 2.44 (s, 3H)
ppm. 13C NMR (100 MHz, CDCl3): δ 175.8, 151.8, 148.0, 145.3,
135.7, 129.8, 128.5, 120.4, 113.1, 63.6, 21.6 ppm. HRMS (ESI)
m/z: calcd for C13H12NaO4S [M+Na]+, 287.0349; found
287.0357.
4.2.23. 1-Phenyl-2-(phenylsulfonyl)ethanone (3aj)
1H NMR (400 MHz, CDCl3): δ 7.97–7.91 (m, 4H), 7.71–7.61(m ,
2H), 7.57 (t, J=7.6 Hz, 2H), 7.50 (t, J=7.4 Hz, 2H), 4.74 (s, 2H)
ppm. 13C NMR (100 MHz, CDCl3): δ 187.9, 138.7, 135.7, 134.4,
129.3, 129.2, 128.8, 128.6, 63.4 ppm. HRMS (ESI) m/z: calcd for
C14H12NaO3S [M+Na]+, 283.0399; found 283.0404.
4.2.15. Ethyl 2-(phenylsulfonyl)acetate (3ab)
1H NMR (400 MHz, CDCl3): δ 7.95 (d, J=7.6 Hz, 2H), 7.69 (t,
J=7.4 Hz, 1H), 7.58 (t, J=7.2 Hz, 2H), 4.16–4.09 (m, 4H), 1.18 (t,
J=7.2 Hz, 3H) ppm. 13C NMR (100 MHz, CDCl3): δ 162.2,
138.7, 134.2, 129.1, 128.4, 62.2, 60.9, 13.7 ppm. HRMS (ESI)
m/z: calcd for C10H12NaO4S [M+Na]+, 251.0349; found
251.0354.
Acknowledgments
We thank the National Natural Science Foundation of China
(21172079), and the Science and Technology Planning Project of
Guangdong Province (2011B090400031) for financial support.
4.2.16. Ethyl 2-((4-fluorophenyl)sulfonyl)acetate (3ac)
1H NMR (400 MHz, CDCl3): δ 8.04–7.95 (m, 2H), 7.27 (t, J=8.4
Hz, 2H), 4.19–4.12 (m, 4H), 1.21 (t, J=7.0 Hz, 3H) ppm. 13C
NMR (100 MHz, CDCl3): δ 167.3, 163.5 (d, JC-F = 250.0 Hz),
134.6, 134.6, 131.5, 131.4, 116.5, 116.3, 62.3, 60.8, 13.7 ppm.
HRMS (ESI) m/z: calcd for C10H11FNaO4S [M+Na]+, 269.0254;
found 269.0259.
References and notes
1. (a) Nielsen, M.; Jacobsen, C. B.; Holub, N.; Paixão, M. W.; Jørgensen,
K. A. Angew. Chem. Int. Ed. 2010, 49, 2668; (b) Meadows, D. C.;
Gervay-Hague, J. Med. Res. Rev. 2006, 26, 793; (c) Alba, A. –N. R.;
Companyó, X.; Rios, R. Chem. Soc. Rev. 2010, 39, 2018.
2.
Peng, H.; Cheng, Y.; Ni, N.; Li, M.; Choudhary, G.; Chou, H. T.; Lu, C.
-D.; Tai, P. C.; Wang, B. ChemMedChem. 2009, 4, 1457.
4.2.17. Ethyl 2-((4-chlorophenyl)sulfonyl)acetate (3ad)
1H NMR (400 MHz, CDCl3): δ 7.90 (d, J=8.8 Hz, 2H), 7.56 (d,
J=8.8 Hz, 2H), 4.16 (q, J=7.2 Hz, 2H), 4.12 (s, 2H), 1.22 (t,
J=7.2 Hz, 3H) ppm. 13C NMR (100 MHz, CDCl3): δ 162.2,
141.1, 137.1, 130.1, 129.5, 62.5, 60.9, 13.8 ppm. HRMS (ESI)
m/z: calcd for C10H11ClNaO4S [M+Na]+, 284.9959; found
284.9965.
3.
(a) Montgomery, J. I.; Brown, M. F.; Reilly, U.; Price, L. M.; Abramite,
J. A.; Arcari, J.; Barham, R.; Che, Y.; Chen, J. M.; Chung, S. W.;
Collantes, E. M.; Desbonnet, C; Doroski, M.; Doty, J.; Engtrakul, J. J.;
Harris, T. M.; Huband, M.; Knafels, J. D.; Leach, K. L.; Liu, S.; Marfat,
A.; McAllister, L.; McElroy, E.; Menard, C. A.; Mitton-Fry, M.;
Mullins, L.; Noe, M. C.; O’Donnell, J.; Oliver, R.; Penzien, J.; Plummer,
M.; Shanmugasundaram, V.; Thoma, C.; Tomaras, A. P.; Uccello, D. P.;
Vaz, A.; Wishka, D. G. J. Med. Chem. 2012, 55, 1662; (b) Aranapakam,
V.; Grosu, G. T.; Davis, J. M.; Hu, B.; Ellingboe, J.; Baker, J. L.;
Skotnicki, J. S.; Zask, A.; DiJoseph, J. F.; Sung, A.; Sharr, M. A.; Killar,
L. M.; Walter, T.; Jin, G.; Cowling, R. J. Med. Chem. 2003, 46, 2361.
4.2.18. Ethyl 2-((4-bromophenyl)sulfonyl)acetateethyl (3ae)
1H NMR (400 MHz, CDCl3): δ 7.82 (d, J=8.0 Hz, 2H), 7.73 (d,
J=7.6 Hz, 2H), 4.16 (q, J=6.8 Hz, 2H), 4.11 (s, 2H), 1.22 (t,
J=7.2 Hz, 3H) ppm. 13C NMR (100 MHz, CDCl3): δ 162.2,
137.7, 132.5, 130.2, 129.8, 62.5, 60.9, 13.9 ppm. HRMS (ESI)
m/z: calcd for C10H11BrNaO4S [M+Na]+, 328.9454; found
328.9452.
4. (a) Mancheño, O. G.; Tangen, P.; Rohlmann, R.; Fröhlich, R.; Alemán, J.
Chem. Eur. J. 2011, 17, 984; (b) Mandai, T.; Yanagi, T.; Araki, K.;
Morisaki, Y.; Kawada, M.; Otera, J. J. Am. Chem. Soc. 1984, 106, 3670;
(c) Kiren, S.; Padwa, A. J. Org. Chem. 2009, 74, 7781; (d) Bin, J. K.;
Lee, J. S.; Kim, K. Org. Lett. 2004, 6, 4297.
5. (a) Thomsen, M. W.; Handwerker, B. M.; Katz, S. A.; Belser, R. B. J.
Org. Chem. 1988, 53, 906; (b) Katritzky, A. R.; Abdel-Fattah, A. A. A.;
Wang, M. J. Org. Chem. 2003, 68, 1443; (c) Becker, H. -D.; Russell, G.
4.2.19. Ethyl 2-([1,1'-biphenyl]-4-ylsulfonyl)acetate (3af) 16